Kurt G. Tournoy

Prof. Dr. Kurt G. Tournoy

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2010 in JAMA
Verified
Journal Article
Open access
PDF file
JAJouke T. Annema
Jouke T. Annema
JMJan P. van Meerbeeck
Jan P. van Meerbeeck
RRRobert C. Rintoul
Robert C. Rintoul
CDChristophe Dooms
Christophe Dooms
EDEllen Deschepper
Ellen Deschepper
Kurt G. TournoyKurt G. Tournoy
Kurt G. Tournoy
Lung cancer is the most commonly diagnosed cancer worldwide (1.35 million/year) and also the most frequent cause of cancer death (1.18 million/year).1 Clinical staging of lung cancer is an integral part of patient care because it directs therapy and has prognostic value. Imaging with computed tomography (CT) is valuable for assessing the primary tumor (T-stage) while fluorodeoxyglucose positron emission tomography (PET) is valuable for detecting metastases. In cases where the primary tumor is resectable and in the absence of distant metastases, mediastinal nodal involvement (N-stage) directs treatment. Surgical resection of the tumor is the treatment of choice in the absence of mediastinal nodal metastases,2 whereas combined modality treatment is indicated for patients with mediastinal nodal metastases.3

15 September 2009 in Allergy
Verified
Journal Article
Closed access
PDF file
SPS. Provoost
S. Provoost
TMT. Maes
T. Maes
YDY. M. Van Durme
Y. M. Van Durme
PGP. Gevaert
P. Gevaert
CBClaus Bachert
Claus Bachert
Kurt G. TournoyKurt G. Tournoy
Kurt G. Tournoy

1 January 2009 in Lung Cancer
Verified
Journal Article
Closed access
Kurt G. TournoyKurt G. Tournoy
Kurt G. Tournoy
RRRobert C. Rintoul
Robert C. Rintoul
JMJan P. van Meerbeeck
Jan P. van Meerbeeck
NCNicholas R. Carroll
Nicholas R. Carroll
MPMarleen Praet
Marleen Praet
JAJouke T. Annema
Jouke T. Annema

1 August 2007 in Thorax
Verified
Journal Article
Open access
PDF file
Kurt G. TournoyKurt G. Tournoy
Kurt G. Tournoy
SMS Maddens
S Maddens
RGR Gosselin
R Gosselin
GMG Van Maele
G Van Maele
JMJ P van Meerbeeck
J P van Meerbeeck
AKA Kelles
A Kelles
Background: Staging of non-small cell lung cancer (NSCLC) is important for determining choice of treatment and prognosis. The accuracy of FDG-PET scans for staging of lymph nodes is too low to replace invasive nodal staging. It is unknown whether the accuracy of integrated FDG-PET/CT scanning makes invasive staging redundant. Methods: In a prospective study, the mediastinal and/or hilar lymph nodes in patients with proven NSCLC were investigated with integrated FDG-PET/CT scanning. Pathological confirmation of all suspect lymph nodes was obtained to calculate the accuracy of the fusion images. In addition, the use of the standardised uptake value (SUV) in the staging of intrathoracic lymph nodes was analysed. Results: 105 intrathoracic lymph node stations from 52 patients with NSCLC were characterised. The prevalence of malignancy in the lymph nodes was 36%. The sensitivity of the integrated FDG-PET/CT scan to detect malignant lymph nodes was 84% and its specificity was 85% (positive likelihood ratio 5.64, negative likelihood ratio 0.19). SUVmax, SUVmean and the SUVmax/SUVliver ratio were all significantly higher in malignant than in benign lymph nodes. The area under the receiver operating curve did not differ between these three quantitative variables, but the highest accuracy was found with the SUVmax/SUVliver ratio. At a cut-off value of 1.5 for the SUVmax/SUVliver ratio, the sensitivity and specificity to detect malignant lymph node invasion were 82% and 93%, respectively. Conclusion: The accuracy of integrated FDG-PET/CT scanning is too low to replace invasive intrathoracic lymph node staging in patients with NSCLC. The visual interpretation of the fusion images of the integrated FDG-PET/CT scan can be replaced by the quantitative variable SUVmax/SUVliver without loss of accuracy for intrathoracic lymph node staging.

16 December 2005 in Respiratory Research
Verified
Journal Article
Open access
PDF file
ADAn I D'Hulst
An I D'Hulst
TMTania Maes
Tania Maes
KBKen R. Bracke
Ken R. Bracke
IDIngel K Demedts
Ingel K Demedts
Kurt G. TournoyKurt G. Tournoy
Kurt G. Tournoy
GBGuy G Brusselle
Guy G Brusselle
Background: Chronic obstructive pulmonary disease is associated with a chronic inflammatory response of the host to chronic exposure to inhaled toxic gases and particles. Although inflammatory cells of both the innate and adaptive immune system infiltrate the lungs in pulmonary emphysema and form lymphoid follicles around the small airways, the exact role of the acquired immune system in the pathogenesis of emphysema is not known.Methods: In this study, wild typeBalb/cmice and immunodeficientscidmice – which lack functional B- and T-cells – were exposed to mainstream cigarette smoke (CS) for 5 weeks or 6 months.Results: Subacute CS-exposure for 5 weeks significantly increased innate inflammatory cells (neutrophils, macrophages and dendritic cells) in the bronchoalveolar lavage (BAL) fluid of wild type mice andscidmice, which correlated with the CS-induced upregulation of the chemokines Monocyte Chemotactic Protein-1, Macrophage Inflammatory Protein-3α and KC (= mouse Interleukin-8). Chronic CS-exposure for 6 months significantly increased the number of neutrophils, macrophages, dendritic cells, CD4+and CD8+T-lymphocytes in BAL fluid and lungs of wild type mice compared to air-exposed littermates, and augmented the size and number of peribronchial lymphoid follicles. In contrast, neither B-lymphocytes, nor T-lymphocytes, nor lymphoid follicles could be discerned in the lungs of air- or CS-exposedscidmice. Importantly, chronic CS-exposure induced pulmonary emphysema in both wild type animals andscidmice, as evidenced by a significant increase in the mean linear intercept and the destructive index of CS-exposed versus air-exposed animals. The CS-induced emphysema was associated with increased mRNA expression of matrix metalloproteinase-12 in the lungs and increased protein levels of Tumor Necrosis Factor-α in the BAL fluid of CS-exposedBalb/candscidmice compared to air-exposed littermates.Conclusion: This study suggests that the adaptive immune system is not required per se to develop pulmonary emphysema in response to chronic CS-exposure, since emphysema can be induced inscidmice, which lack lymphoid follicles as well as functional B- and T-cells.

21 January 2010 in Respiratory Research
Verified
Journal Article
Open access
PDF file
TMTania Maes
Tania Maes
SPSharen Provoost
Sharen Provoost
ELEllen A Lanckacker
Ellen A Lanckacker
DCDidier D Cataldo
Didier D Cataldo
Jeroen VanoirbeekJeroen Vanoirbeek
Jeroen Vanoirbeek
GJGuy F Joos
Guy F Joos
Air pollutant exposure has been linked to a rise in wheezing illnesses. Clinical data highlight that exposure to mainstream tobacco smoke (MS) and environmental tobacco smoke (ETS) as well as exposure to diesel exhaust particles (DEP) could promote allergic sensitization or aggravate symptoms of asthma, suggesting a role for these inhaled pollutants in the pathogenesis of asthma. Mouse models are a valuable tool to study the potential effects of these pollutants in the pathogenesis of asthma, with the opportunity to investigate their impact during processes leading to sensitization, acute inflammation and chronic disease. Mice allow us to perform mechanistic studies and to evaluate the importance of specific cell types in asthma pathogenesis. In this review, the major clinical effects of tobacco smoke and diesel exhaust exposure regarding to asthma development and progression are described. Clinical data are compared with findings from murine models of asthma and inhalable pollutant exposure. Moreover, the potential mechanisms by which both pollutants could aggravate asthma are discussed.